Delivery Order SPE2DB24D1107-SPE2DB25FZGL9
- Not listed
- The Defense Logistics Agency awarded a $3,313.05 delivery order to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 gm) on August 29, 2025, with an ultimate completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $1,385.34 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on August 1, 2025, with a completion date of August 4, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a $9,867 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 grams) on August 25, 2025, with completion targeted for August 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,005.82 to AmerisourceBergen Drug Corp for Advair HFA 115-21 mcg inhalers (12 grams) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order will be fulfilled...
- The Defense Logistics Agency awarded a $2,416.18 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 grams). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award through open procurement. Performance is based in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,601.36 to AmerisourceBergen Drug Corp for Advair HFA 230-21 microgram inhalers (12 grams) under a firm fixed price contract, with an ultimate completion date of September 3, 2025. This non-set-aside competitive award represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Advair HFA 115-21 micrograms inhaler in 12-gram units, valued at $9,119.12. The award is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Advair HFA 115-21 microgram inhalers (12 gram units) with a ceiling value of $1,476.11. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,068.76 to AmerisourceBergen Drug Corp for Advair HFA 45-21 microgram inhalers (12 grams) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price contract represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,335.16 to AmerisourceBergen Drug Corp for Advair HFA 115-21 microgram inhalers (12 grams) on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a small-value transaction under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZGL9Delivery Order
The Defense Logistics Agency awarded a $2,618.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 grams) on September 2, 2025, with completion scheduled for September 3, 2025. This non-competitive, non-set-aside award was issued to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's comprehensive pharmaceutical supply portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for respiratory medication supports the company's ongoing role as a primary global pharmaceutical supplier under the DLA's medical supply chain, enabling flexible fulfillment of federal healthcare requirements across diverse military and defense-related healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/2/25 |